Malignant Hyperthermia in a Myopathic Child. Prolonged Postoperative Course Requiring Dantrolene
- 1 October 1982
- journal article
- research article
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 26 (5) , 435-438
- https://doi.org/10.1111/j.1399-6576.1982.tb01795.x
Abstract
An 18-mo.-old boy with congenital muscular dystrophy began to develop clear signs of the malignant hyperthermia syndrome after 85 min of halothane/N2O anesthesia. Dantrolene, 2 mg/kg i.v., was immediately effective, but temperature, heart rate and CO2 production were all increased for 2 days postoperatively in spite of repeated dantrolene administration.This publication has 14 references indexed in Scilit:
- Malignant Hyperthermia Following Preoperative Oral Administration of DantroleneAnesthesiology, 1981
- Central core disease and malignant hyperthermia syndromeAnnals of Neurology, 1980
- Recrudescence after Survival of an Initial Episode of Malignant HyperthermiaAnesthesiology, 1979
- latrogenic Benign Hyperthermia in ChildrenAnesthesiology, 1978
- Malignant Hyperthermia and Central Core Disease in a Child With Congenital Dislocating HipsArchives of Neurology, 1978
- Congenital Muscular Dystrophy: A Clinico-Pathological and Follow-Up Study of 15 PatientsNeuropediatrics, 1975
- Anesthetic-induced malignant hyperpyrexia in childrenThe Journal of Pediatrics, 1973
- INHERITANCE OF MALIGNANT HYPERPYREXIAThe Lancet, 1972
- Malignant hyperthermia: A statistical reviewCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1970
- A MYOPATHIC FAMILY; WITH HYPERTROPHIC, PSEUDO-HYPERTROPHIC, ATROPHIC AND TERMINAL (DISTAL IN UPPER EXTREMITIES) STAGES.Brain, 1932